Acorda Therapeutics, Inc. Restricted Cash, Current
Acorda Therapeutics, Inc. had Restricted Cash, Current of $718.00 thousand as of 2024-03-31, per its 10-Q filed 2024-05-14.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Restricted Cash and Cash Equivalent, Current
us-gaap:RestrictedCashCurrent · last filed 2024-05-14
- 2024-03-31: Restricted Cash, Current $718.00K.
- 2023-12-31: Restricted Cash, Current $381.00K.
- 2023-09-30: Restricted Cash, Current $861.00K.
- 2023-06-30: Restricted Cash, Current $828.00K.
| Period end | Restricted Cash, Current |
|---|---|
| 2024-03-31 | $718.00K 10-Q · filed 2024-05-14 |
| 2023-12-31 | $381.00K 10-Q · filed 2024-05-14 |
| 2023-09-30 | $861.00K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $828.00K 10-Q · filed 2023-08-09 |
| 2023-03-31 | $6.99M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $6.88M 10-K · filed 2024-04-01 |
| 2022-09-30 | $13.23M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $13.11M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $13.39M 10-Q · filed 2022-05-13 |
| 2021-12-31 | $13.40M 10-K · filed 2023-03-15 |
| 2021-09-30 | $13.35M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $12.88M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $13.05M 10-Q · filed 2021-05-12 |
| 2020-12-31 | $12.92M 10-K · filed 2022-03-18 |
| 2020-09-30 | $13.20M 10-Q · filed 2020-11-06 |
| 2020-06-30 | $13.02M 10-Q · filed 2020-08-07 |
| 2020-03-31 | $13.18M 10-Q · filed 2020-05-08 |
| 2019-12-31 | $12.84M 10-K · filed 2021-03-16 |
| 2018-12-31 | $532.00K 10-K · filed 2020-02-28 |